210820-99-8,
Fmoc-L-His(Boc)-OH DCHA,
Fmoc-His(-Boc)-OH,
Fmoc-His(Boc)-OH CHA,
Fmoc-His(Boc)-OH cyclohexylammonium salt,
Fmoc-L-His(Boc)-OH CHA,
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-histidine cyclohexanamine,
C26H27N3O6.C6H13N,
PubChem12426,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-n-im-(t-butyloxycarbonyl)-L-histidine cyclohexylamine,
Fmoc-His(Boc)-OHCHA,
DTXSID20583800,
CF-184,
AKOS016014022,
Fmoc-His(Boc)-OH cyclohexylamine salt,
V1357,
K-6073,
379N524,
Nim-Boc-N|A-Fmoc-L-histidine cyclohexylammonium salt,
N(Im)-Boc-N-alpha-Fmoc-L-histidine cyclohexylamine salt,
N|A-Fmoc-N(im)-Boc-L-histidine cyclohexylammonium salt,
1-(tert-Butoxycarbonyl)-N-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-histidine--cyclohexanamine (1/1),
L-Histidine, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, compd. with cyclohexanamine (1:1),
fmoc-his(1-boc)-oh,
Fmoc-His(Boc)-OH,
81379-52-4,
L-Histidine, 1-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, compd. with cyclohexanamine (1:1) (9CI); cyclohexanamine (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(1-(tert,